v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   291,489,058        
Beginning balance at Dec. 31, 2024 $ 29,632 $ 2,915 $ (48) $ 366,938 $ 48 $ (340,221)
Increase (Decrease) in Stockholders' Equity            
Stock-based compensation expense 1,885     1,885    
Issuance of common stock for stock option exercises and restricted stock unit vesting, net (in shares)   660,917        
Issuance of common stock for stock option exercises and restricted stock unit vesting, net (245) $ 7   (252)    
Other comprehensive income (8)       (8)  
Net loss (15,350)         (15,350)
Ending balance (in shares) at Mar. 31, 2025   292,149,975        
Ending balance at Mar. 31, 2025 $ 15,914 $ 2,922 (48) 368,571 40 (355,571)
Beginning balance (in shares) at Dec. 31, 2025 312,379,972 312,501,472        
Beginning balance at Dec. 31, 2025 $ (12,166) $ 3,125 (48) 392,763 61 (408,067)
Increase (Decrease) in Stockholders' Equity            
Stock-based compensation expense 2,061     2,061    
Issuance of common stock for stock option exercises and restricted stock unit vesting, net (in shares)   938,927        
Issuance of common stock for stock option exercises and restricted stock unit vesting, net 88 $ 9   79    
Issuance of common stock for capital raises, net (in shares)   15,000,000        
Issuance of common stock for capital raises, net 20,721 $ 150   20,571    
Issuance of common stock upon exercise of warrants (in shares)   10,000,000        
Issuance of common stock upon exercise of warrants 14,175 $ 100   14,075    
Other comprehensive income 103       103  
Net loss $ (19,177)         (19,177)
Ending balance (in shares) at Mar. 31, 2026 338,318,899 338,440,399        
Ending balance at Mar. 31, 2026 $ 5,805 $ 3,384 $ (48) $ 429,549 $ 164 $ (427,244)